Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 13, Issue SUPPL. 1, 2003, Pages

  Wagner, Karen Dineen ^a   Cook, Edwin H ^b   Chung, Henry ^c   Messig, Michael ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SERTRALINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPEPSIA; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; HYPERKINESIA; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; OBSESSIVE COMPULSIVE DISORDER; OPEN STUDY; PSYCHOTHERAPY; RATING SCALE; REMISSION; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

ADOLESCENT; AGING; CHILD; FEMALE; HUMANS; LONG-TERM CARE; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0037961069     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., rev. (DSM-III-R). Washington (DC), American Psychiatric Association, 1987.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
3. Ballenger JC: Treatment of anxiety disorders to remission. J Clin Psychiatry 62(Suppl 12):5-9, 2001.
4. Bolton D, Luckie M, Steinberg D: Long-term course of obsessive-compulsive disorder treated in adolescence. J Am Acad Child Adolesc Psychiatry 34: 1441-1450, 1995.
5. Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M: Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 40:1175-1181, 2001.
6. DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P: Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45-49, 1992.
7. Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, Rasmussen SA: Patterns of remission and relapse in obsessive-compulsive disorder: A 2-year prospective study. J Clin Psychiatry 60:346-351, 1999.
8. Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG: Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 40:773-779, 2001.
9. Grados M, Scahill L, Riddle MA: Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am 8:617-634, 1999.
10. Guy W: ECDEU Assessment Manual for Psychopharmacology, rev. (DHEW publication no. ADM 76-338). Rockville (Maryland), National Institute of Mental Health, 1976.
11. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, Rapoport JL: A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 48:922-927, 1991.
12. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H: Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA 280:1752-1756, 1998.
13. March J, Frances A, Kahn D, Carpenter D: Expert Consensus guidelines: treatment of obsessive-compulsive disorder. J Clin Psychiatry 58(suppl 4): 1-72, 1997.
14. Murphy DL, Pickar D, Alterman IS: Methods for the quantitative assessment of depressive and manic behavior. In: The Behavior of Psychiatric Patients, Burdock EL, Sudilovsky A, Gershon S eds. New York: Marcel Dekker pp 355-392, 1982.
15. Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghom JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222-229, 2001.
16. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF: Children's Yale-Brown Obsessive-Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852, 1997.
17. Walkup JT, Reeve E, Yaryura-Tobias J, Wong L, Claghorn J, Greist J, Holland D, McConville B, Pigott T, Pravetz M, Riddle M. Fluvoxamine for childhood OCD: Long-term treatment. Anaheim (California), 45th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 1998 (abstract NR-69).
18. Zohar AH: The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 8:445-460, 1999.